LogiPharma Europe 2023: Wayne Rothman Discusses Building Digital Capabilities into Workflows

A panel of experts examines how stakeholders can support strategies that improve patient outcomes, while also navigating various distribution models.

Claire Riches highlights inefficiencies in the current drug approval process, while outlining the role of payers and insurers in shifting toward data-driven approval framework.

Doug Long, VP, industry relations, IQVIA, examines shifting pharmaceutical trends, including specialty growth, biosimilar gaps, reimbursement pressure from GLP-1s, and persistent access challenges.

Rob Sobie outlines the importance of supply chain transparency for the benefit of patients.

Brett Casper explores the marketplace complexities that manufacturers face regularly.

A session dives into the trends surrounding specialty drugs and therapies, along with providing an overview of the drug development landscape.